文献速递儿童青少年精神会诊联络精神医学

注意缺陷多动障碍用药与机动车碰撞风险的关联

Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes.
PubMed 文献 · JAMA Psychiatry · 2017-01-01

结果显示,男性用药月份风险降低38%(OR 0.62,95%CI 0.56-0.67),女性降低42%(OR 0.58,95%CI 0.53-0.62),各年龄组结果相似。

要点

  • ADHD患者用药月份机动车碰撞急诊风险显著低于未用药月份。
  • 男性风险降低38%(OR 0.62,95%CI 0.56-0.67),女性降低42%(OR 0.58,95%CI 0.53-0.62)。
  • 若全程用药,最多22.1%的ADHD患者机动车碰撞或可避免。

核心结论

  • ADHD患者在接受药物治疗的月份机动车碰撞急诊就诊率低于未用药月份。

研究设计与样本

  • 采用个体内分析比较患者用药月份与未用药月份的机动车碰撞风险。

主要发现

  • 男性ADHD患者用药月份机动车碰撞风险降低38%(OR 0.62,95%CI 0.56-0.67)。
  • 女性ADHD患者用药月份机动车碰撞风险降低42%(OR 0.58,95%CI 0.53-0.62)。
  • 各年龄组及多项敏感性分析均发现类似降低,长期关联分析结果一致。
  • 人群归因分数估计显示,若全程随访期间用药,最多22.1%的ADHD患者机动车碰撞可避免。

临床怎么用

  • 临床应关注ADHD患者机动车碰撞风险,药物治疗或有助于降低该风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Motor vehicle crashes (MVCs) are a major public health problem. Research has demonstrated that individuals with attention-deficit/hyperactivity disorder (ADHD) are more likely to experience MVCs, but the effect of ADHD medication treatment on the risk of MVCs remains unclear. OBJECTIVE: To explore associations between ADHD medication use and risk of MVCs in a large cohort of patients with ADHD. DESIGN, SETTING, AND PARTICIPANTS: For this study, a US national cohort of patients with ADHD (n = 2 319 450) was identified from commercial health insurance claims between January 1, 2005, and December 31, 2014, and followed up for emergency department visits for MVCs. The study used within-individual analyses to compare the risk of MVCs during months in which patients received ADHD medication with the risk of MVCs during months in which they did not receive ADHD medication. EXPOSURES: Dispensed prescription of ADHD medications. MAIN OUTCOMES AND MEASURES: Emergency department visits for MVCs. RESULTS: Among 2 319 450 patients identified with ADHD, the mean (SD) age was 32.5 (12.8) years, and 51.7% were female. In the within-individual analyses, male patients with ADHD had a 38% (odds ratio, 0.62; 95% CI, 0.56-0.67) lower risk of MVCs in months when receiving ADHD medication compared with months when not receiving medication, and female patients had a 42% (odds ratio, 0.58; 95% CI, 0.53-0.62) lower risk of MVCs in months when receiving ADHD medication. Similar reductions were found across all age groups, across multiple sensitivity analyses, and when considering the long-term association between ADHD medication use and MVCs. Estimates of the population-attributable fraction suggested that up to 22.1% of the MVCs in patients with ADHD could have been avoided if they had received medication during the entire follow-up. CONCLUSIONS AND RELEVANCE: Among patients with ADHD, rates of MVCs were lower during periods when they received ADHD medication. Considering the high prevalence of ADHD and its association with MVCs, these findings warrant attention to this prevalent and preventable cause of mortality and morbidity.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chang Z, Quinn PD, Hur K, et al. Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes. JAMA Psychiatry. 2017. PMID: 28492937. doi:10.1001/jamapsychiatry.2017.0659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。